NICE rejects asthma drug for under-12s

NICE has rejected asthma drug omalizumab (Xolair) for children under the age of 12 in the NHS in England and issued guidance on fracture prevention, bed-wetting treatments and the diabetes drug liraglutide.

Omalizumab is recommended for some over-12s, but NICE said that the evidence for use in younger children suggested the drug offered limited benefits over other treatments. The extra cost of the drug would not therefore represent good value for money, it concluded.

But the guidance states that children currently receiving omalizumab should be able to continue with the treatment until it is considered appropriate to stop.

This week the institute recommended denosumab (Prolia) as a treatment option for some postmenopausal women at increased risk of osteoporotic fractures if other treatments available on the NHS are unsuitable.

NICE has also published the first national guidance on how to treat children and young people who wet the bed. In a change to current clinical practice, the institute has not specified a minimum age limit in its new clinical guideline on the assessment and management of this condition.

The institute said the new recommendations meant healthcare professionals would now be more likely to consider whether younger children may benefit from appropriate advice and treatments currently available on the NHS.

NICE has issued final guidance approving the use of the drug liraglutide for certain diabetes patients. PCTs must now fund the drug for eligible patients recommended for treatment with it by their clinicians. Draft guidance on liraglutide was issued in September. The final guidance setting out which patients are eligible for treatment is available on the NICE website.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GP practices face losses 'in excess of £50,000' as COVID-19 hits income

GP practices face losses 'in excess of £50,000' as COVID-19 hits income

GP practices across England are facing a significant loss of income as COVID-19 dries...

MPs explore GP workload cap and flag damaging impact of intense pressure

MPs explore GP workload cap and flag damaging impact of intense pressure

MPs have raised the prospect of a cap on GP consultations in an investigation into...

GP training: Working remotely as a GP trainee during the pandemic

GP training: Working remotely as a GP trainee during the pandemic

Dr Zoe Brown was in her first year of GP training and pregnant as lockdown began....

GPs warn government off PCN-led test and trace system

GPs warn government off PCN-led test and trace system

GPs have rebuffed suggestions that primary care networks (PCNs) are ‘best placed’...

Map: Three-fold variation in GP practice list size between CCGs

Map: Three-fold variation in GP practice list size between CCGs

The list size of GP practices across England has grown rapidly over the past decade...

Advance decisions to refuse treatment - what GPs need to know

Advance decisions to refuse treatment - what GPs need to know

A recent case has underlined the need for GPs to communicate a patient’s known wishes...